source
- AstraZeneca halts several mid- and late-stage trials after efficacy setbacksAstraZeneca announced it has stopped a number of mid- and late-stage clinical trials in its pipeline over recent months. The decision follows disappointing efficacy results in those studies, limit…
- AI researcher Kyunghyun Cho leaves Genentech to explore pharma applications at Endpoints AI DayKyunghyun Cho, a noted AI researcher, announced that he has left Genentech to pursue independent work in pharmaceutical applications of machine learning. He will discuss his new focus at Endpoints…